Tesofensine: Side Effects & Safety
Part of the Tesofensine Complete Guide
Research Peptides
We may earn a commission if you purchase through this link, at no extra cost to you.
Overall Safety Profile
Tesofensine's cardiovascular effects — elevated heart rate and blood pressure — have been the primary barrier to regulatory approval. The FDA and EMA have required additional cardiovascular safety data before approving monoamine reuptake inhibitors for obesity following historical concerns with similar mechanisms.
Reported Side Effects
- Elevated heart rate: Mean +7–8 bpm at therapeutic doses
- Dry mouth: Very common (noradrenergic effect)
- Insomnia: Due to dopamine and norepinephrine elevation
- Constipation: Serotonergic effect
- Mood changes: Anxiety, irritability in some participants
- Blood pressure: Modest increases
Important Limitations
Long-term cardiovascular safety data is absent. The monoamine mechanism raises concerns about abuse potential (dopamine), serotonin syndrome (drug interactions), and cardiovascular events with prolonged use. Not FDA-approved.
Contraindications
- Uncontrolled hypertension or cardiovascular disease
- History of stroke or MI
- Concurrent use of MAOIs or SSRIs (serotonin syndrome risk)
- Anxiety disorders (may worsen symptoms)
- Pregnancy and breastfeeding